<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.eurjchem.com/lib/pkp/xml/oai2.xsl" ?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/
		http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
	<responseDate>2026-04-14T00:12:04Z</responseDate>
	<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:ojs.www.eurjchem.com:article/1586">https://www.eurjchem.com/index.php/eurjchem/oai</request>
	<GetRecord>
		<record>
			<header>
				<identifier>oai:ojs.www.eurjchem.com:article/1586</identifier>
				<datestamp>2017-09-30T11:59:49Z</datestamp>
				<setSpec>eurjchem:SC</setSpec>
				<setSpec>driver</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Synthesis of quinazolinones derivatives an antiproliferative agent against human lung carcinoma cells</dc:title>
	<dc:creator>Deshmukh, Satish Uttamrao</dc:creator>
	<dc:creator>Kharat, Kiran Ramesh</dc:creator>
	<dc:creator>Kadam, Gajanan Gulabrao</dc:creator>
	<dc:creator>Pawar, Rajendra Pundlikrao</dc:creator>
	<dc:subject xml:lang="en-US">Ionic liquid</dc:subject>
	<dc:subject xml:lang="en-US">Green chemistry</dc:subject>
	<dc:subject xml:lang="en-US">2-Aminobenzamide</dc:subject>
	<dc:subject xml:lang="en-US">Antiproliferative activity</dc:subject>
	<dc:subject xml:lang="en-US">Lung carcinoma A549 cells</dc:subject>
	<dc:subject xml:lang="en-US">2</dc:subject>
	<dc:subject xml:lang="en-US">3‐Dihydroquinazolin‐4(1H)‐one</dc:subject>
	<dc:description xml:lang="en-US">2,3‐Dihydroquinazolin‐4(1H)‐one derivatives (3a-p) were synthesized in excellent yields. These compounds were screened for antiproliferative activity against A549 cells and were found as potent cytotoxicity. Compounds A4, A8, A10 found to be more promising antiproliferative against the lung carcinoma A549 cells. IC50 values for compounds A4, A8 and A10 were found to be 8.6, 8.9 and 8.1 μg/L against A549 cells, respectively.</dc:description>
	<dc:publisher xml:lang="en-US">Atlanta Publishing House LLC</dc:publisher>
	<dc:date>2017-09-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://www.eurjchem.com/index.php/eurjchem/article/view/1586</dc:identifier>
	<dc:identifier>10.5155/eurjchem.8.3.317-320.1586</dc:identifier>
	<dc:source xml:lang="en-US">European Journal of Chemistry; Vol. 8 No. 3 (2017): September 2017; 317-320</dc:source>
	<dc:source>2153-2257</dc:source>
	<dc:source>2153-2249</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://www.eurjchem.com/index.php/eurjchem/article/view/1586/pdf_1586</dc:relation>
</oai_dc:dc>
			</metadata>
		</record>
	</GetRecord>
</OAI-PMH>
